172 related articles for article (PubMed ID: 30909802)
1. The impact of antecedent primary malignancy in soft tissue sarcoma patients.
Torigoe T; Imanishi J; Yazawa Y; Kadono Y; Oda H
J Orthop Surg (Hong Kong); 2019; 27(2):2309499019838124. PubMed ID: 30909802
[TBL] [Abstract][Full Text] [Related]
2. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
[TBL] [Abstract][Full Text] [Related]
6. Primary high-grade soft-tissue sarcoma of the buttock: a rare but distinct clinical entity.
Soyfer V; Corn BW; Bickels J; Merimsky O
Br J Radiol; 2016 Jun; 89(1062):20151017. PubMed ID: 27043867
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 251 cases of soft tissue sarcomas].
Shi YQ; Zong XY; Wang J; Li S
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):116-8. PubMed ID: 12783673
[TBL] [Abstract][Full Text] [Related]
8. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
9. Modified staging system for extremity soft tissue sarcomas.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in soft tissue sarcoma.
el-Jabbour JN; Akhtar SS; Kerr GR; McLaren KM; Smyth JF; Rodger A; Leonard RC
Br J Cancer; 1990 Nov; 62(5):857-61. PubMed ID: 2245181
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
13. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients.
Cany L; Stoeckle E; Coindre JM; Kantor G; Bonichon F; Bui BN
J Surg Oncol; 1999 May; 71(1):4-9. PubMed ID: 10362084
[TBL] [Abstract][Full Text] [Related]
15. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
16. Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas.
Sasaki H; Nagano S; Komiya S; Taniguchi N; Setoguchi T
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29899304
[TBL] [Abstract][Full Text] [Related]
17. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
Collier CD; Kim CY; Liu RW; Getty PJ
Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
[TBL] [Abstract][Full Text] [Related]
18. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
19. Actual long-term survival after resection of stage III soft tissue sarcoma.
Lee DW; Kim HS; Han I
BMC Cancer; 2021 Jan; 21(1):21. PubMed ID: 33402132
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler M; Gosheger G; Jobke B; Reichardt P; Tunn PU
Br J Cancer; 2015 Feb; 112(3):455-60. PubMed ID: 25535732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
